Technical Analysis for RVX - Resverlogix Corp.

Grade Last Price % Change Price Change
grade D 1.72 -3.91% -0.070
RVX closed up 19.33 percent on Monday, November 11, 2019, on 1.22 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical RVX trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish -3.91%
Pocket Pivot Bullish Swing Setup -3.91%
Wide Bands Range Expansion -3.91%
Above Upper BB Strength -3.91%
Gapped Up Strength -3.91%
Upper Bollinger Band Touch Strength -3.91%
Wide Bands Range Expansion 14.67%
Narrow Range Bar Range Contraction 26.47%
NR7 Range Contraction 26.47%
Wide Bands Range Expansion 26.47%

Older signals for RVX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Resverlogix Corp. is a clinical-stage biotechnology company. The Company is a development-stage company, which is engaged in developing apabetalone (RVX-208), a first-in-class small molecule selective Bromodomain and ExtraTerminal domain (BET) inhibitor. Apabetalone is used for the treatment of patients with high-risk cardiovascular disease, (including peripheral arterial disease), diabetes mellitus, chronic kidney disease, Alzheimer's disease and orphan diseases. Apabetalone is being investigated in a Phase III clinical trial for the secondary prevention of major adverse cardiovascular events (MACE) in high risk patients with diabetes mellitus and chronic kidney disease. The Company initiated a Phase III clinical trial BETonMACE with apabetalone in high-risk cardiovascular disease patients with low high-density lipoprotein. It focuses on conducting a proof-of-concept clinical trial in patients with Paroxysmal Nocturnal Hemoglobinuria. The Company has not generated any revenues.
Medicine Biotechnology Medical Specialties RTT Alzheimer's Disease Chronic Condition Diabetes Mellitus
Is RVX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.94
52 Week Low 0.35
Average Volume 268,950
200-Day Moving Average 2.8786
50-Day Moving Average 1.8016
20-Day Moving Average 1.337
10-Day Moving Average 1.376
Average True Range 0.2185
ADX 16.77
+DI 37.6708
-DI 20.5171
Chandelier Exit (Long, 3 ATRs ) 1.2845
Chandelier Exit (Short, 3 ATRs ) 1.5954999999999999
Upper Bollinger Band 1.6957
Lower Bollinger Band 0.9783
Percent B (%b) 1.13
BandWidth 53.657442
MACD Line -0.04
MACD Signal Line -0.1308
MACD Histogram 0.0908
Fundamentals Value
Market Cap 205.18 Million
Num Shares 115 Million
EPS -0.52
Price-to-Earnings (P/E) Ratio -3.44
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.375
Resistance 3 (R3) 2.360 2.150 2.278
Resistance 2 (R2) 2.150 2.001 2.158 2.245
Resistance 1 (R1) 1.970 1.909 2.060 1.985 2.212
Pivot Point 1.760 1.760 1.805 1.768 1.760
Support 1 (S1) 1.580 1.611 1.670 1.595 1.368
Support 2 (S2) 1.370 1.519 1.378 1.335
Support 3 (S3) 1.190 1.370 1.303
Support 4 (S4) 1.205